AU2006292328B2 - Novel crystal forms of irinotecan hydrochloride - Google Patents

Novel crystal forms of irinotecan hydrochloride Download PDF

Info

Publication number
AU2006292328B2
AU2006292328B2 AU2006292328A AU2006292328A AU2006292328B2 AU 2006292328 B2 AU2006292328 B2 AU 2006292328B2 AU 2006292328 A AU2006292328 A AU 2006292328A AU 2006292328 A AU2006292328 A AU 2006292328A AU 2006292328 B2 AU2006292328 B2 AU 2006292328B2
Authority
AU
Australia
Prior art keywords
irinotecan hydrochloride
irinotecan
forms
iii
pxrd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2006292328A
Other languages
English (en)
Other versions
AU2006292328A1 (en
Inventor
Shu-Ping Chen
Piin-Jye Harn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scinopharm Singapore Pte Ltd
Original Assignee
Scinopharm Singapore Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scinopharm Singapore Pte Ltd filed Critical Scinopharm Singapore Pte Ltd
Publication of AU2006292328A1 publication Critical patent/AU2006292328A1/en
Application granted granted Critical
Publication of AU2006292328B2 publication Critical patent/AU2006292328B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2006292328A 2005-09-20 2006-09-19 Novel crystal forms of irinotecan hydrochloride Ceased AU2006292328B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US71882705P 2005-09-20 2005-09-20
US60/718,827 2005-09-20
PCT/US2006/036437 WO2007035709A2 (en) 2005-09-20 2006-09-19 Novel crystal forms of irinotecan hydrochloride

Publications (2)

Publication Number Publication Date
AU2006292328A1 AU2006292328A1 (en) 2007-03-29
AU2006292328B2 true AU2006292328B2 (en) 2012-12-20

Family

ID=37889452

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2006292328A Ceased AU2006292328B2 (en) 2005-09-20 2006-09-19 Novel crystal forms of irinotecan hydrochloride

Country Status (14)

Country Link
US (1) US7435818B2 (enExample)
EP (2) EP2082741A1 (enExample)
JP (1) JP5119153B2 (enExample)
KR (1) KR101150504B1 (enExample)
CN (1) CN101277694B (enExample)
AR (1) AR056082A1 (enExample)
AT (1) ATE460162T1 (enExample)
AU (1) AU2006292328B2 (enExample)
BR (1) BRPI0616308A2 (enExample)
CA (1) CA2623117C (enExample)
DE (1) DE602006012871D1 (enExample)
ES (1) ES2343204T3 (enExample)
NZ (1) NZ566807A (enExample)
WO (1) WO2007035709A2 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101318964B (zh) * 2007-06-07 2010-12-15 上海迪赛诺医药发展有限公司 盐酸伊立替康新晶型及其制备方法
US7572803B2 (en) * 2007-10-25 2009-08-11 The Christus Stehlin Foundation For Cancer Research Hydrated crystalline esters of camptothecin
IT1391757B1 (it) * 2008-11-11 2012-01-27 Antibioticos Spa Irinotecan cloridrato cristallino e metodi per la sua preparazione
US8546573B2 (en) 2009-11-18 2013-10-01 Cadila Healthcare Limited Process for the preparation of 7-ethyl-10-[4-(1-piperidino)-1-piperdino] carbonyloxy-camptothecin hydrochloride trihydrate
WO2012007952A1 (en) * 2010-07-12 2012-01-19 Hetero Research Foundation Novel polymorph of irinotecan hydrochloride
CN102311443B (zh) * 2011-08-24 2014-07-16 上海北卡医药技术有限公司 盐酸伊立替康的新晶型及其制备方法
CN102617584B (zh) * 2012-03-14 2013-10-16 海南锦瑞制药股份有限公司 一种盐酸伊立替康化合物及其药物组合物
CN102850363B (zh) * 2012-09-18 2013-07-10 山东罗欣药业股份有限公司 盐酸伊立替康化合物及其药物组合物
EP2986739B1 (en) 2013-04-15 2018-04-04 Regeneron Pharmaceuticals, Inc. Markers of tumor cell response to anti-cancer therapy
CN105713004A (zh) * 2016-03-23 2016-06-29 杭州华东医药集团新药研究院有限公司 一种高品质盐酸伊立替康三水合物晶型的制备方法
US10919905B2 (en) * 2019-05-16 2021-02-16 Scinopharm Taiwan, Ltd. Polymorphism for irinotecan free base

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074527A1 (en) * 2002-03-01 2003-09-12 Pharmacia Italia S.P.A. Crystalline polymorphic form of irinotecan hydrochloride
WO2006084941A2 (en) * 2005-02-08 2006-08-17 Fermion Oy Process for the preparation of irinotecan hydrochloride

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6019790A (ja) 1983-07-14 1985-01-31 Yakult Honsha Co Ltd 新規なカンプトテシン誘導体
MA24682A1 (fr) * 1997-10-23 1999-07-01 Smithkline Beecham Corp Formes polymorphes nouvelles de cipamfylline, procede pour leur preparation et compositions les contenant
SK9742002A3 (en) * 2000-01-07 2003-02-04 Transform Pharmaceuticals Inc High-throughput formation, identification, and analysis of diverse solid-forms
CZ20022250A3 (cs) * 2002-06-27 2004-02-18 Pliva-Lachema A. S. Způsob výroby irinotekanu
AU2004215560B2 (en) 2003-02-25 2009-09-24 Kabushiki Kaisha Yakult Honsha Method for preparing polymorphism of irinotecan hydrochloride
WO2006016203A1 (en) * 2004-08-09 2006-02-16 Shilpa Medicare Limited An improved process for the preparation of irinotecan hydrochloride trihydrate
US20060046993A1 (en) * 2004-09-01 2006-03-02 Pharmacia Italia S.P.A. Crystalline polymorphic form of irinotecan hydrochloride
ATE446299T1 (de) * 2005-02-07 2009-11-15 Fermion Oy Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003074527A1 (en) * 2002-03-01 2003-09-12 Pharmacia Italia S.P.A. Crystalline polymorphic form of irinotecan hydrochloride
WO2006084941A2 (en) * 2005-02-08 2006-08-17 Fermion Oy Process for the preparation of irinotecan hydrochloride

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Sawada et al., Chem. Pharm. Bull., 39(6), 1991, pages 1446-1454 *

Also Published As

Publication number Publication date
AU2006292328A1 (en) 2007-03-29
CA2623117A1 (en) 2007-03-29
US20070072890A1 (en) 2007-03-29
ES2343204T3 (es) 2010-07-26
KR20080059244A (ko) 2008-06-26
DE602006012871D1 (de) 2010-04-22
WO2007035709A3 (en) 2007-10-25
CA2623117C (en) 2013-12-10
EP1951235A4 (en) 2008-10-29
CN101277694B (zh) 2011-04-20
BRPI0616308A2 (pt) 2011-06-14
NZ566807A (en) 2011-05-27
WO2007035709A2 (en) 2007-03-29
JP2009508874A (ja) 2009-03-05
AR056082A1 (es) 2007-09-19
CN101277694A (zh) 2008-10-01
EP1951235A2 (en) 2008-08-06
EP2082741A1 (en) 2009-07-29
US7435818B2 (en) 2008-10-14
JP5119153B2 (ja) 2013-01-16
EP1951235B1 (en) 2010-03-10
KR101150504B1 (ko) 2012-07-09
ATE460162T1 (de) 2010-03-15

Similar Documents

Publication Publication Date Title
DE60214359T2 (de) Stickstoffbasierte camptothecin-derivate
JP7818701B2 (ja) 多環式カルバモイルピリドン誘導体およびその製造方法と薬物組成物
EP1487840B1 (en) Crystalline polymorphic form of irinotecan hydrochloride
CA2623117C (en) Novel crystal forms of irinotecan hydrochloride
KR20230019110A (ko) 4-아미노-5-(6-(4-메틸피페라진-1-일)-1H-벤조[D]이미다졸-2-일)티에노[2,3-b]피리딘-6(7H)-온(one)의 염 및 결정형
CN114736214B (zh) 一种倍半萜衍生物、其药物组合物及其制备方法和用途
CA2516643C (en) Method for preparing polymorphism of irinotecan hydrochloride
RU2352572C2 (ru) Пентагидрат моногидрохлорида топотекана в кристаллической форме, соответствующие композиции на их основе, способы получения и/или способы лечения
RU2561118C2 (ru) Производные камптотецина, обладающие противоопухолевой активностью
US8349863B2 (en) Crystalline polymorphic form of a camptothecin analogue
CN113024557B (zh) 一种Peganumine A生物碱结构简化物及其应用
CN113754659A (zh) 含螺环的喹唑啉化合物
HK40064722A (en) Polymorph of cdk9 inhibitor and preparation method for polymorph and use thereof
ZA200603508B (en) Novel compound, corresponding compositions, preparation and/or treatment methods

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired